HealthQuad has announced an investment in LifeSigns, an AI-powered remote patient monitoring platform focused on predictive healthcare solutions.
The investment aligns with HealthQuad’s healthcare innovation-led investment strategy aimed at supporting the shift from reactive healthcare models to continuous and predictive patient monitoring. The partnership is expected to strengthen LifeSigns’ integrated patient monitoring platform while accelerating its expansion into Southeast Asia and GCC markets through access to Quadria’s healthcare ecosystem.
LifeSigns has developed an AI-powered remote monitoring platform designed to continuously monitor patients and detect early signs of deterioration, enabling timely clinical intervention. The company’s solution has been deployed across tier 2 cities and follows an occupancy-based pricing model aimed at improving access to quality healthcare.
According to HealthQuad, healthcare systems globally are facing rising demand, workforce shortages, and increasing cost pressures, making continuous patient monitoring increasingly critical. The investment reflects HealthQuad’s focus on healthcare technologies that can deliver measurable clinical outcomes at scale.
Rahul Agarwal, Partner, HealthQuad, said, “Healthcare today is built on periodic observation while risk is real time. The future lies in continuous monitoring led predictive intelligence. LifeSigns is building that layer to detect deterioration early and enable timely intervention which can significantly improve outcomes and reduce healthcare costs at scale. This is a globally relevant model and where the next wave of healthcare will be built. With access to Quadria’s ecosystem, we are well positioned to help Hari and LifeSigns team to scale across global markets.”
Hari Subramaniam, Founder and CEO, LifeSigns, said, “No patient should deteriorate silently because systems are not designed to continuously monitor them. That belief built LifeSigns. Our platform has demonstrated both clinical impact and scalability in India. With HealthQuad and Quadria, we now have the strategic depth to take this model global and make predictive care the standard.”
The global remote patient monitoring devices market is estimated at US$26 billion in 2025, driven by the transition towards decentralised and continuous care models.
LifeSigns has developed a US-FDA-approved continuous monitoring platform integrating a medical-grade wearable device, cloud dashboard, and predictive AI engine. The platform supports monitoring across ambulances, emergency rooms, ICUs, hospital wards, and home care settings.
The system tracks vital parameters including ECG, heart rate, respiration, temperature, blood pressure, and oxygen saturation. According to the company, its AI engine can detect early signs of deterioration up to 26 hours in advance and identify critical risks within a four-hour window.
LifeSigns stated that across more than 50 hospitals in India, the platform has generated over 87,000 life-saving alerts, reduced code blue incidents by nearly 90 per cent, and lowered ICU readmissions by close to 78 per cent.
Send news announcements/press releases to:
editor@thefoundermedia.com
